On September 25, 2024, Krsnaa Diagnostics Ltd, a leading provider of diagnostic services in India, announced a strategic investment in Apulki Healthcare Private Limited.
This partnership marks India’s first Public Private Partnership (PPP) focused on cancer and cardiac care hospitals. Through this collaboration, Krsnaa will provide a wide range of integrated diagnostic services at Apulki’s facilities, improving access to advanced diagnostic options.
Krsnaa will serve as the exclusive diagnostics partner for Apulki’s modern cancer and cardiac hospitals for over 30 years. This long-term agreement solidifies Krsnaa’s position in the growing fields of oncology and cardiac diagnostics, with access to Apulki’s plan for more than 10 hospitals across India. The first phase will include two advanced hospitals with over 125 beds each, located in densely populated areas of Pune and Mumbai, with plans for additional hospitals in other major cities.
This initiative aims to address the rising demand for specialised diagnostics and improve patient outcomes for individuals from all socioeconomic backgrounds. Krsnaa and Apulki will offer advanced diagnostic technologies like MRI, PET CT, cardiac CT, and advanced pathology, which are available 24/7 under one roof. The partnership’s goal is to promote early detection, enhance treatment accuracy, and ultimately improve survival rates through timely and precise diagnoses.
Mr Yash Mutha, Joint Managing Director of Krsnaa Diagnostics Ltd, stated, “This investment is more than just a strategic partnership; it’s a game-changer in the Indian healthcare landscape. By acquiring a stake in Apulki, we are positioning ourselves at the forefront of the rapidly expanding cancer and cardiac care segment. ”
He further added, “ The investment is subject to the fulfilment of certain conditions precedent, and the exact amount will be disclosed once we sign the definitive documents. However, it is important to note that this investment will not put any strain on our cash flows, as it will be funded entirely through internal accruals over the next 2-3 months. This partnership also marks a significant milestone for Krsnaa on the retail front, as it enables us to establish comprehensive diagnostic centres in premium urban locations. ”
Krsnaa Diagnostics Ltd is the fastest-growing diagnostic services provider in India, specialising in both Radiology and Pathology. The company began in 2011 with just 2 radiology centres and has since expanded to over 2,900 centres across 18 states and union territories in the country.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
